Want to see FR:GDS full AI Analyst Report?
GDS Stock Chart & Stats
€9.34
€0.00(0.00%)
At close: 4:00 PM EST
€9.34
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€8.72 - €11.55
Previous CloseN/A
Volume15.00
Average Volume (3M)31.35K
Market Cap
€1.24B
Enterprise Value€5.07B
Total Cash (Recent Filing)€216.20M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding110,389,690
10 Day Avg. Volume445
30 Day Avg. Volume31,348
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.06
Price to Sales (P/S)0.23
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GrowthA 25.21% free cash flow growth rate and strong operating cash flow relative to net income indicate durable cash generation. This supports debt servicing, capital expenditure, and potential reinvestment in facilities or services, providing financial flexibility despite earnings volatility.
Stable Reimbursement-driven RevenueRelying on France's statutory health insurance creates a predictable, structural revenue base. Modest but stable revenue growth reflects steady patient demand and reimbursement flows, reducing cyclicality and supporting multi-month operational planning and capacity utilization.
Large Clinical Network And Service MixA broad network across acute, maternity, emergency and post-acute services offers scale and cross-referral advantages. Diversified care lines and a large staff footprint enable operational efficiencies, bargaining strength with suppliers/payers, and resilience to localized demand shifts.
Bears Say
Negative Profitability And ROEPersistent net losses and a negative ROE signal the company is not generating sufficient operating earnings to reward equity holders. Over the medium term this constrains retained earnings, limits self-funded expansion, and heightens reliance on external financing or restructuring to restore profitability.
High LeverageElevated debt-to-equity increases fixed financial obligations and refinancing risk, reducing strategic flexibility. In a sector with regulated reimbursements, high leverage can pressure margins if reimbursement rates stagnate or interest costs rise, constraining investments and cushion for downturns.
Cash Flow-profitability DisconnectA gap between strong free cash flow and negative accounting profits suggests non-cash charges, high financing costs, or one-time items are depressing reported earnings. This undermines confidence in sustained earnings recovery and complicates assessment of recurring operating profitability.
Ramsay Generale de Sante News
GDS FAQ
What was Ramsay Generale de Sante SA’s price range in the past 12 months?
Ramsay Generale de Sante SA lowest stock price was €8.72 and its highest was €11.55 in the past 12 months.
What is Ramsay Generale de Sante SA’s market cap?
Ramsay Generale de Sante SA’s market cap is €1.24B.
When is Ramsay Generale de Sante SA’s upcoming earnings report date?
Ramsay Generale de Sante SA’s upcoming earnings report date is Aug 20, 2026 which is in 36 days.
How were Ramsay Generale de Sante SA’s earnings last quarter?
Currently, no data Available
Is Ramsay Generale de Sante SA overvalued?
According to Wall Street analysts Ramsay Generale de Sante SA’s price is currently Overvalued.
Does Ramsay Generale de Sante SA pay dividends?
Ramsay Generale de Sante SA pays a Semiannually dividend of €0.791 which represents an annual dividend yield of N/A. See more information on Ramsay Generale de Sante SA dividends here
What is Ramsay Generale de Sante SA’s EPS estimate?
Ramsay Generale de Sante SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante SA have?
Ramsay Generale de Sante SA has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ramsay Generale de Sante SA?
Currently, no hedge funds are holding shares in FR:GDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ramsay Generale de Sante SA
Ramsay Générale de Santé S.A., headquartered in Paris, France, manages a network of hospitals across the nation. These facilities provide a wide spectrum of healthcare services, including specialized care in anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity management, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology. Furthermore, they conduct various surgical procedures such as thoracic, vascular, and endovascular interventions. Founded in 1987, the company adopted its current name in December 2015, having previously been known as Générale de Santé SA. Ramsay Générale de Santé S.A. functions as a subsidiary of Ramsay Health Care Limited.